Immunome (IMNM) Cash & Current Investments (2019 - 2026)
Immunome's Cash & Current Investments was $520.01 million in Q2 2026, up 94.0% from $268.08 million a year earlier but down 10.8% from the prior quarter.
Immunome (IMNM) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Immunome came in at $653.48 million, up 200.7% from FY2024.
- Cash & Current Investments has now increased for three consecutive years, with a five-year compound annual growth rate of 75.0% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $217.3 million in FY2024 (+57.3%), $138.14 million in FY2023 (+579.7%), $20.32 million in FY2022 (-58.7%) and $49.23 million in FY2021 (+23.8%).
- Quarterly Cash & Current Investments has moved between $20.32 million (Q4 2022) and $653.48 million (Q4 2025) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for four straight quarters, with growth averaging 76.6% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q3 2021 (growth of 734.0%); the worst was Q4 2022 (a decline of 58.7%).
- Per Business Quant data, IMNM's Cash & Current Investments in the three quarters before Q2 2026 was $582.7 million (Q1 2026), $653.48 million (Q4 2025) and $272.64 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Immunome | 2.37 Bn | 341.22 Mn | - | 520.01 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 520.01 Mn |
| Mar 31, 2026 | 582.70 Mn |
| Dec 31, 2025 | 653.48 Mn |
| Sep 30, 2025 | 272.64 Mn |
| Jun 30, 2025 | 268.08 Mn |
| Mar 31, 2025 | 317.32 Mn |
| Dec 31, 2024 | 217.30 Mn |
| Sep 30, 2024 | 240.17 Mn |
| Jun 30, 2024 | 278.35 Mn |
| Mar 31, 2024 | 309.72 Mn |
| Dec 31, 2023 | 138.14 Mn |
| Sep 30, 2023 | 90.64 Mn |
| Jun 30, 2023 | 38.42 Mn |
| Mar 31, 2023 | 44.42 Mn |
| Dec 31, 2022 | 20.32 Mn |
| Sep 30, 2022 | 27.08 Mn |
| Jun 30, 2022 | 34.65 Mn |
| Mar 31, 2022 | 42.88 Mn |
| Dec 31, 2021 | 49.23 Mn |
| Sep 30, 2021 | 56.24 Mn |
Immunome Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMNM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();